Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance.
Mithu MaheswaranathanBruce MillerNatasha UngRashmi SinhaCarly HarrisonBugra Han EgeliHuseyin Berk DegirmenciEmily SirotichJean W LiewRebecca GraingerEugenia Y ChockPublished in: Clinical rheumatology (2023)
Most respondents found telemedicine at least as effective as in-person visits. Participants found telemedicine to be effective for specific scenarios, such as making medication changes and discussion of disease activity. Telemedicine may continue to be of importance in the care of patients with rheumatic diseases post pandemic, but likely for specific subsets of patients for specific visit indications. Key Points • Most patients with rheumatic disease found telemedicine as effective as in-person visits, particularly for some indications.
Keyphrases
- disease activity
- rheumatoid arthritis
- coronavirus disease
- sars cov
- juvenile idiopathic arthritis
- systemic lupus erythematosus
- healthcare
- end stage renal disease
- rheumatoid arthritis patients
- newly diagnosed
- ankylosing spondylitis
- ejection fraction
- climate change
- palliative care
- emergency department
- patient reported outcomes
- pain management